Zhejiang Hisoar Pharmaceutical Co Ltd (002099) — Cash Flow Quality Index
Zhejiang Hisoar Pharmaceutical Co Ltd (002099) has a Cash Flow Quality Index of 5.37x as of June 2025. Operating cash flow of CN¥26.13 Million exceeds net income of CN¥4.86 Million, indicating high earnings quality where cash backs reported profits. Explore long-term investment intensity of Zhejiang Hisoar Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Hisoar Pharmaceutical Co Ltd Cash Flow Quality Index (2003–2022)
Historical Cash Flow Quality Index for Zhejiang Hisoar Pharmaceutical Co Ltd across 19 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Zhejiang Hisoar Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Zhejiang Hisoar Pharmaceutical Co Ltd (2003–2022)
Year-by-year earnings quality comparison for Zhejiang Hisoar Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Zhejiang Hisoar Pharmaceutical Co Ltd (002099) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.35x | CN¥116.09 Million | CN¥86.08 Million | ▲ +23.7% |
| 2021 | 1.09x | CN¥102.36 Million | CN¥93.87 Million | ▼ -34.7% |
| 2020 | 1.67x | CN¥533.87 Million | CN¥319.70 Million | ▲ +110.2% |
| 2019 | 0.79x | CN¥612.40 Million | CN¥770.78 Million | ▼ -39.3% |
| 2018 | 1.31x | CN¥791.45 Million | CN¥605.00 Million | ▲ +336.2% |
| 2017 | 0.30x | CN¥102.68 Million | CN¥342.36 Million | ▼ -89.3% |
| 2016 | 2.80x | CN¥629.42 Million | CN¥224.56 Million | ▲ +209.0% |
| 2015 | 0.91x | CN¥462.16 Million | CN¥509.50 Million | ▼ -78.9% |
| 2014 | 4.29x | CN¥191.56 Million | CN¥44.66 Million | ▼ -52.0% |
| 2012 | 8.94x | CN¥180.73 Million | CN¥20.22 Million | ▲ +903.9% |
| 2011 | 0.89x | CN¥92.62 Million | CN¥104.04 Million | ▼ -57.7% |
| 2010 | 2.11x | CN¥180.88 Million | CN¥85.87 Million | ▼ -35.0% |
| 2009 | 3.24x | CN¥98.38 Million | CN¥30.38 Million | ▲ +169.7% |
| 2008 | 1.20x | CN¥30.61 Million | CN¥25.49 Million | ▼ -26.2% |
| 2007 | 1.63x | CN¥51.14 Million | CN¥31.44 Million | ▲ +38.7% |
| 2006 | 1.17x | CN¥61.88 Million | CN¥52.78 Million | ▲ +63.7% |
| 2005 | 0.72x | CN¥36.07 Million | CN¥50.36 Million | ▼ -39.6% |
| 2004 | 1.19x | CN¥42.36 Million | CN¥35.70 Million | ▲ +597.4% |
| 2003 | -0.24x | CN¥-5.45 Million | CN¥22.86 Million | — |